Vaxcyte Inc. ( PCVX ) on Monday released topline results from its Phase 2 dose-finding study evaluating the safety, tolerability and immunogenicity of VAX-24, a 24-valent pneumococcal conjugate vaccine (PCV) candidate designed to prevent invasive pneumococcal disease (IPD), compared to Pfizer Inc’s Prevnar 20 (PCV20) in healthy infants. The company has selected the VAX-24 Mid-dose as the basis for advancing an optimized...

08:59 AM EDT, 03/31/2025 (MT Newswires) -- Alnylam Pharmaceuticals ( ALNY ) said late Friday that the US Food and Drug Administration approved Qfitlia, a therapy designed to lower antithrombin, a protein inhibiting blood clotting. The company said Qfitlia is approved for routine prophylaxis to prevent or reduce bleeding episodes in adults and pediatric patients with hemophilia A or B....

08:58 AM EDT, 03/31/2025 (MT Newswires) -- Nouveau Monde Graphite ( NMG ) was 2.7% higher at last look Monday in NYSE pre-market trading after reporting a higher net loss for 2024, but a narrower loss per share. The company reported a 2024 net and comprehensive loss of $73.3 million, or $0.71 per share, compared to a 2023 net and...

08:55 AM EDT, 03/31/2025 (MT Newswires) -- Monday's flash estimate of German inflation for March brought further relief for the European Central Bank as headline inflation came in at 2.2% year-on-year, down from 2.3% in February, said ING. Core inflation came down to 2.5% year over year from 2.6%. The European inflation measure dropped to 2.3% year over year from...